 | Halozyme Therapeutics (NASDAQ:HALO) Price Target Cut to $43.00
marketbeat.com - January 26 at 7:38 AM |
 | Halozyme Therapeutics (NASDAQ:HALO) PT Lowered to $43.00 at Piper Sandler
americanbankingnews.com - January 26 at 8:26 AM |
 | Halozyme issues lower than expected guidance for 2022
seekingalpha.com - January 10 at 11:19 AM |
 | Halozyme Therapeutics Issues 2022 Guidance; Projects Revenue Growth Of 23-26%
nasdaq.com - January 10 at 11:19 AM |
 | HALOZYME PROVIDES 2022 FINANCIAL GUIDANCE AND OUTLOOK
finance.yahoo.com - January 10 at 11:19 AM |
| Halozyme Therapeutics (NASDAQ:HALO) Releases FY22 Earnings Guidance
americanbankingnews.com - January 10 at 8:36 AM |
| Financial Survey: Cardiff Oncology (NASDAQ:CRDF) vs. Halozyme Therapeutics (NASDAQ:HALO)
americanbankingnews.com - January 7 at 6:30 PM |
| Halozyme to Present Virtually at the 40th Annual J.P. Morgan Health Care Conference
finance.yahoo.com - January 4 at 1:22 PM |
| HALOZYME APPOINTS NEW GENERAL COUNSEL
finance.yahoo.com - December 13 at 9:01 PM |
 | The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares
markets.businessinsider.com - December 10 at 12:41 PM |
| HALOZYME ANNOUNCES $750 MILLION THREE-YEAR SHARE REPURCHASE PROGRAM
finance.yahoo.com - December 9 at 5:55 PM |
|
| Halozyme Therapeutics (HALO) Investor Presentation - Slideshow
seekingalpha.com - December 7 at 5:58 PM |
| Halozyme Therapeutics (HALO) Down 19.7% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - December 2 at 2:43 PM |
| Halozyme Announces Janssen Receives U.S. FDA Approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in Combination with Carfilzomib and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse
finance.yahoo.com - December 1 at 6:10 PM |
| Here's Why I Think Halozyme Therapeutics (NASDAQ:HALO) Is An Interesting Stock
finance.yahoo.com - November 5 at 10:19 AM |
| Halozyme's Q3 Sales Boosted By Darzalex; Lifts FY21 Earnings Outlook
finance.yahoo.com - November 3 at 3:40 PM |
 | Halozyme Therapeutics, inc (HALO) Q3 2021 Earnings Call Transcript
fool.com - November 3 at 12:11 AM |
 | Halozyme Therapeutics (HALO) Q3 Earnings and Revenues Top Estimates
msn.com - November 2 at 7:20 PM |
| Halozyme Reports Third Quarter 2021 Results
finance.yahoo.com - November 2 at 7:20 PM |
| Should You Buy Halozyme (HALO) Ahead of Earnings?
finance.yahoo.com - November 1 at 12:59 PM |
| Why the Earnings Surprise Streak Could Continue for Halozyme Therapeutics (HALO)
finance.yahoo.com - October 28 at 3:01 PM |
| Halozyme To Host Third Quarter 2021 Financial Results Webcast and Conference Call
finance.yahoo.com - October 19 at 4:54 PM |
| First Week of June 2022 Options Trading For Halozyme Therapeutics (HALO)
nasdaq.com - October 15 at 6:50 PM |
 | Notable Halozyme Therapeutics Insider Trades $2.7M In Company Stock
feeds.benzinga.com - October 5 at 10:59 AM |
| Michael J Labarre
benzinga.com - October 4 at 6:39 PM |
| Notable Halozyme Therapeutics Insider Trades $1.6M In Company Stock
finance.yahoo.com - October 4 at 6:39 PM |
| Halozyme Therapeutics, Inc. 2021 Q2 - Results - Earnings Call Presentation
seekingalpha.com - August 13 at 6:37 PM |
| Halozyme Therapeutics: Q2 Earnings Insights
benzinga.com - August 10 at 12:18 AM |
| Halozyme Therapeutics, inc (HALO) Q2 2021 Earnings Call Transcript
finance.yahoo.com - August 10 at 12:18 AM |
| BRIEF-Halozyme Reports Second Quarter 2021 Results
msn.com - August 9 at 7:17 PM |
| Halozyme Therapeutics, Inc. Q2 adjusted earnings Beat Estimates
nasdaq.com - August 9 at 7:17 PM |
| Halozyme Reports Second Quarter 2021 Results
finance.yahoo.com - August 9 at 7:17 PM |
| Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Beat Estimates
finance.yahoo.com - August 9 at 7:17 PM |
| Why Halozyme (HALO) Might Surprise This Earnings Season
finance.yahoo.com - August 5 at 12:48 PM |
|
| Halozyme Therapeutics (HALO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
finance.yahoo.com - August 2 at 6:08 PM |
| Halozyme to Participate in Canaccord Genuity 41st Annual Growth Conference
finance.yahoo.com - July 30 at 12:43 PM |
| Halozyme To Host Second Quarter 2021 Financial Results Webcast and Conference Call
finance.yahoo.com - July 27 at 5:51 PM |
| The Big Winner With Johnson & Johnson's Recent FDA Approval
finance.yahoo.com - July 23 at 9:33 AM |
| The Halozyme Therapeutics (NASDAQ:HALO) Share Price Has Soared 355%, Delighting Many Shareholders
nasdaq.com - July 19 at 12:25 PM |
| Analyzing Halozyme Therapeutics's Unusual Options Activity
benzinga.com - July 18 at 8:16 PM |
| Janssen's Darzalex Faspro Wins FDA Approval In Combination With Pomalidomide, Dexamethasone For Multiple Myeloma
finance.yahoo.com - July 12 at 1:24 PM |
| Halozyme Announces Janssen Receives U.S. FDA Approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse
finance.yahoo.com - July 12 at 8:24 AM |
 | Antidiabetics Market Share Growth, Size Value, Trends, Rigonal outlook by 2028
marketwatch.com - June 28 at 1:01 PM |
| Halozyme (HALO) Inks Collaboration Deal With Glaxo's HIV Unit
finance.yahoo.com - June 23 at 11:50 AM |
| Halozyme Announces Janssen Receives European...
benzinga.com - June 22 at 5:42 PM |
| Halozyme Announces Janssen Receives European Marketing Authorizations for DARZALEX® (daratumumab) Subcutaneous Formulation for Newly Diagnosed Systemic Light-chain Amyloidosis and Pre-Treated Multiple Myeloma
finance.yahoo.com - June 22 at 5:42 PM |
| Halozyme Collaborates with ViiV Healthcare to Develop Ultra-Long-Acting HIV Meds
finance.yahoo.com - June 22 at 12:42 PM |
| Glaxo (GSK)/Vir Affirm COVID-19 Drug Cuts Hospitalization/Death
finance.yahoo.com - June 22 at 12:42 PM |
| Glaxo Will Face Investors Wednesday. Here’s What to Know.
finance.yahoo.com - June 22 at 12:42 PM |
| Did You Miss Halozyme Therapeutics' (NASDAQ:HALO) Whopping 399% Share Price Gain?
finance.yahoo.com - June 17 at 2:34 PM |
| Why Is Halozyme Therapeutics (HALO) Down 7.5% Since Last Earnings Report?
finance.yahoo.com - June 9 at 2:28 PM |
